AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2015
Oct 9, 2015
31949_dirs_2015-10-09_461f9d6b-1447-4177-a0a8-410768799dd0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-07
Reporting Person: Perlhagen Gert L. (Director, 10% Owner)
Reporting Person: Volati Ltd (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-07 | Ordinary Shares | C | 5755705 | — | Acquired | 7531378 | Indirect |
| 2015-10-09 | Ordinary Shares | X | 154601 | $3.54 | Acquired | 7685979 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-07 | Series A Convertible Preferred Shares | $ | C | 131380 | Disposed | Ordinary Shares (131380) | Indirect | |
| 2015-10-07 | Series C Convertible Preferred Shares | $ | C | 618411 | Disposed | Ordinary Shares (618411) | Indirect | |
| 2015-10-07 | Series D Convertible Preferred Shares | $ | C | 829546 | Disposed | Ordinary Shares (829546) | Indirect | |
| 2015-10-07 | Series E Convertible Preferred Shares | $ | C | 2823670 | Disposed | Ordinary Shares (2823670) | Indirect | |
| 2015-10-07 | Series F Convertible Preferred Shares | $ | C | 1121329 | Disposed | Ordinary Shares (1121329) | Indirect | |
| 2015-10-07 | Series G Convertible Preferred Shares | $ | C | 231369 | Disposed | Ordinary Shares (231369) | Indirect | |
| 2015-10-09 | Warrants | $3.54 | X | 154601 | Disposed | 2015-10-11 | Ordinary Shares (154601) | Indirect |
Footnotes
F1: Mr. Perlhagen is the settlor of, and a beneficiary of shares held by, the Oden Trust, the beneficial owner of Volati Limited.
F2: Currently exercisable as of the date hereof.
F3: N/A.
F4: Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series automatically converted into ordinary shares upon the consummation of the issuer's initial public offering on October 7, 2015.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3